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The Autographa californica multinucleocapsid poly-
hedrosis virus homologous region sequence hr1 en-
hances transcription from the viral polyhedrin pro-
moter in Spodoptera frugiperda insect cells and
independently functions as an origin of replication (ori)
sequence. The binding of the host nuclear protein, hr1-
binding protein (hr1-BP), is crucial for the enhancer
activity (Habib, S., Pandey, S., Chatterji, U., Burma, S.,
Ahmad, R., Jain, A., and Hasnain, S. E. (1996) DNA Cell
Biol. 15, 737–747 and Habib, S., and Hasnain, S. E. (1996)
J. Biol. Chem. 271, 28250–28258). We demonstrate that
hr1 can also enhance transcription from non-baculovi-
ral promoters like cytomegalovirus and hsp70 in mam-
malian cells but does not support ori activity in these
cells. Unlike insect cells, hr1 can also function in mam-
malian cells as an enhancer when present in trans. hr1
DNA sequence binds with high affinity and specificity to
nuclear factors in the mammalian cells. The insect hr1-
BP- and the hr1-BP-like proteins from mammalian cells
(mhr1-BP) have different properties with respect to ion
requirements, DNA groove binding, and molecular size.
When mammalian cells are infected with a recombinant
baculovirus containing two promoters, the baculovirus
polyhedrin and Drosophila hsp70 gene promoter, the
hsp70 gene promoter alone is active in these cells, and
this activity is further enhanced by the presence of an
additional hr1 in the recombinant virus. hr1 may thus
also have a role in baculovirus-mediated gene delivery
in mammalian cells.
Enhancers are genetic elements that up-regulate gene ex-
pression by enhancing transcription of genes, even when placed
several thousand nucleotides away in a position or orientation-
independent fashion. The SV40 enhancer, the first enhancer to
be discovered (1, 2) and the most extensively studied, repre-
sents the best example of a prototypical enhancer that func-
tions in a wide variety of cell types from different species. It is
even active in non-mammalian systems like Xenopus laevis
kidney cells or even in the green alga Acetabularia, and, in
some cases, it can confer cell specificity or host-range response
to the promoter (3, 4).
The baculovirus Autographa californica multinucleocapsid
nuclear polyhedrosis virus (AcMNPV)1 genome consists largely
of unique sequences. Interspersed, however, are nine homolo-
gous region (hr) sequences called hr1, hr1a, hr2, hr2a, hr3,
hr4a, hr4b, hr4c, and hr5 (5, 6). The hrs vary in length from 150
to 800 bp and have a modular structure containing two to eight
imperfect, 30-bp palindromes with an EcoRI site at the center
of each palindrome. Homologous region 1 (hr1) has been shown
to be an enhancer for the immediate early gene ie-N and de-
layed early gene 39k (7). We earlier reported that hr1 enhances
transcription from the polyhedrin promoter in a classic enhanc-
er-like manner (8–10). hr1-mediated enhancement is position-
and orientation-independent and can activate transcription to
about 10-fold in a plasmid-based transient expression system
and to more than 90-fold when inserted as an additional copy
within the viral genome (10). Enhancement mediated by hr1
follows the temporal profile of very late gene expression (20–60
h.p.i.) and was a direct function of the number of modules (8).
hr1 is bifunctional, i.e. it is both a transcriptional enhancer and
an ori of replication (8), and these functions of hr1 are inde-
pendent of each other. Although the palindrome alone is suffi-
cient for the ori function, the palindrome plus the flanking
sequence is essential for the enhancer function. A host cell
protein, named hr1-BP (9), which binds very specifically to the
palindrome plus the flanking sequence, is required for the
enhancer function. We also showed that hr1 can stimulate
expression from other homologous promoters like the AcMNPV
late promoter cor (8) and very late promoter p10 and from
heterologous promoters such as Drosophila hsp70 in insect
cells.2
In this study, we describe the ability of the baculovirus hr1 to
function as an enhancer, both when placed in cis as well as
trans, but not as an ori sequence in heterologous mammalian
cells. These cells also contain protein factors that bind to hr1,
but these binding proteins are distinct from hr1-BP present in
insect cells. This enhancement of gene expression can be ex-
ploited for the development of improved vectors for baculovi-
rus-mediated gene delivery in mammalian cells.
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EXPERIMENTAL PROCEDURES
Cells and Virus—Spodoptera frugiperda cells (Sf9) were grown in
TNMFH medium (Invitrogen) containing 10% fetal bovine serum as
described previously (11). All the mammalian cell lines used namely,
Vero (African monkey kidney epithelial cell line), COS-1 (African green
monkey kidney fibroblast-like, SV40-transformed cell line), HepG2 (hu-
man hepatocyte cell line), HeLa (human adenocarcinoma cell line), and
PS-1 (porcine kidney cell line) cell lines were cultured in Dulbecco’s
modified Eagle’s medium containing high glucose. The C6 strain of wild
type AcMNPV was used in infection experiments. Recombinant viruses
vAclacluc and vAclacluc-hr1 were constructed (10, 11) using pBacPAK8
(Clontech, Palo Alto, CA) baculovirus transfer vectors as per standard
procedures. The recombinant viruses were purified and titrated, and
viral infection was carried out at a multiplicity of infection of 10 for each
virus. To ascertain that equal amounts of viral DNA from the different
recombinants had entered the insect cells, equal amounts of the reac-
tion mixtures were dot-blotted onto a nylon membrane after the lucif-
erase assay, followed by probing with the luc cDNA and densitometric
scanning (8).
Plasmid Constructs—Plasmid pBVluc was constructed by cloning a
3.695-kb fragment from pCEP-X2-luc (containing the CMV promoter,
luciferase reporter, and SV40 polyadenylation signal) into the SalI site
within the multiple cloning site of pUC18 to generate a 6.38-kb plasmid.
pBVluc was linearized by partially digesting with SalI and was ligated
to a 750-bp hr1 fragment, released as SalI fragment from pSHhr1 (9), to
construct various plasmids with different positions, orientation and
number of hr1 (Fig. 1A). pBVluc-hr1-U1 (7.13 kb) and pBVluc-hr1-U2
(7.13 kb) have hr1 cloned upstream to the CMV promoter in the same or
opposite orientation, respectively, as present in the viral genome rela-
tive to the polyhedrin promoter. pBVluc-hr1-U1-U1 (7.88 kb) and pBV-
luc-hr1-D1-D1 have two copies of hr1 in the correct orientation upstream
or downstream to the promoter, respectively. pBVluc-hr1-D1 and pBV-
luc-hr1-D2 have a single hr1 placed downstream to the CMV-luc con-
struct in the right or wrong orientation, respectively.
Transient Transfection Assays—Transfection of reporter plasmids
into Sf9 insect cells was carried out using Lipofectin as described
previously (8). Mammalian cell transfections were performed using the
reagent LipofectAMINE Plus (Invitrogen). Equal numbers of cells were
plated onto 6-well plates. Before transfection, the cells were repeatedly
washed with serum-free media to remove all traces of sera. 3 g of
plasmid was diluted in 100 l of serum-free medium, 6 l of Plus
reagent was added to this, and the DNA-Plus mix was incubated for 15
min. This was then added to another tube containing 4 l of Lipo-
fectAMINE diluted in 100 l of serum-free medium and incubated
together for another 15 min, and the DNA LipofectAMINE complex was
added to cells and the volume was made up to 1 ml. After 6 h, 1 ml of
20% fetal bovine serum-containing media was added to the cells fol-
lowed by infection with either wild type or recombinant viruses or
transfected with transfer vector plasmid DNAs. Aliquots of infected
and/or transfected cells were harvested at different time points, and
luciferase or -galactosidase enzyme expression levels were monitored
as described (8, 11). All the experiments, both transfections and viral
infections, were repeated in duplicate, at least three times. To com-
pletely rule out artifacts caused by unequal amounts of transfected
DNA entering the cells, it was ascertained that equal amounts of
plasmid DNA from the different constructs had entered the insect cells.
For this, equal amounts of the reaction mixture, after the respective
reporter enzyme assays, were dot-blotted on a nylon membrane and
probed with the luc DNA or lacZ DNA as described, followed by densi-
tometric scanning of the dot blots.
Electrophoretic Mobility Shift Assay—Nuclear protein extracts were
prepared from Sf9 cells or the mammalian cells using a modified
method (9, 12). Binding reactions with nuclear extracts from both insect
and mammalian cells were carried out by incubating 2 g of nuclear
extract with end-labeled fragments of hr1. The reaction was carried out
in a buffer containing 250 mM NaCl, 10 mM Tris-Cl, pH 7.5, 1 mM
dithiothreitol, 20% glycerol, and 1 g (1000-fold excess) of poly(dI-dC)
at 4 °C for 15 min. The reaction was loaded on a 4.5% polyacrylamide
gel and fractionated at 150 V in TAE buffer (40 mM Tris-acetate and 1
mM EDTA). In competition experiments, a 20- or 40-fold molar excess of
the unlabeled competitor was added to the reaction prior to the addition
of the nuclear extract. For studying the effects of various ions on the
DNA-protein binding, the salt containing the ion was added to the
reaction buffer at the required concentration. To study the inhibition
with minor and major groove-binding drugs, the hr1 probe was incu-
bated for 30 min at room temperature with varying concentrations of
distamycin A or methyl green and then analyzed for binding by incu-
bation with the nuclear extract.
DpnI Sensitivity Assay—Plasmid DNA (2 g) was transfected into
insect and mammalian cells, followed by infection with wild type AcM-
NPV virus after 24 h or no infection at all as mentioned in the respective
figure legends. The total cell DNA was isolated at different time points
post transfection or infection as described (8) and resuspended in 25 l
of water. To assay for replication, 5 l of DNA was digested with
HindIII to linearize the plasmid and with both HindIII and DpnI to
score for DpnI sensitivity (9). The digested DNA was Southern-trans-
ferred and hybridized to 32P-labeled pUC18 probe.
RESULTS
hr1 Enhances Transcription from the CMV Promoter in a
Position- and Orientation-independent Manner in Mammalian
Cells—hr1 is a classic enhancer of transcription from the Ac-
MNPV promoters in Sf9 insect cells. To check if hr1 can en-
hance CMV promoter-driven expression in mammalian cells,
transient transfections were performed. The luciferase expres-
sion from Vero cells, transiently transfected with reporter plas-
mids (Fig. 1A) carrying hr1 sequence, was compared with cells
transfected with pBVluc lacking the hr1 sequence. The pres-
ence of hr1 upstream and in the same orientation relative to
the CMV promoter as in the viral genome (pBVluc-hr1-U1), or
upstream but in opposite orientation or downstream in either
orientation results in 3-fold increase in luciferase expression
over the control plasmid pBVluc (Fig. 1B). Interestingly, con-
structs carrying two copies of the hr1 sequence in an upstream
or downstream position did not generate any additional effect.
Transient transfection experiments with the same constructs
were performed in other mammalian cells. About similar en-
hancement of hr-1-mediated luciferase expression was ob-
served in HepG2 cells and PS-1 cells irrespective of the position
and orientation of hr1 relative to the CMV promoter (results
not shown). When the same CMV promoter-containing plas-
mids were transfected into Sf9 cells, a 2.6-fold enhancement is
observed (data not shown). These results suggest that hr1 can
function as an enhancer of CMV promoter in both mammalian
cells and Sf9 cells in a classic enhancer-like fashion.
hr1 Can Enhance Expression from Other Promoters and Re-
porters in Mammalian Cells—To check if hr1-mediated tran-
scriptional enhancement works with other promoters and re-
porters, the plasmid pBVlacluc-hr1 was used. This plasmid
contains the hsp70 promoter-driven -galactosidase, and the
baculovirus polyhedrin promoter-driven luciferase along with a
copy of the hr1 sequence element. The expression of the lacZ
reporter from cells transfected with this plasmid was compared
with a plasmid pUlacluc that did not carry the hr1 sequence. In
Vero cells, about 3-fold increase in -galactosidase expression
in the hr1-containing plasmid over the control plasmid is ob-
served (Fig. 2). The enhancement effected by hr1 is more or less
similar irrespective of the constructs used (data not shown).
COS-1 cells and HepG2 cells also show hr1-mediated increase
in transcription, although to a slightly reduced level compared
with Vero cells (data not shown). hr1 can, therefore, enhance
expression of -galactosidase from hsp70 promoter in different
heterologous host cells.
hr1 Can Also Function When Present in trans in Mammalian
Cells—Enhancers are basically cis-acting DNA elements. In
the recent years, there have been various reports of enhancers
capable of working also in trans (13, 14). Experiments were
accordingly designed to check if hr1, unlike in insect cells, can
also function in trans in mammalian cells. pBVluc (a vector
lacking hr1 sequence but with the CMV promoter driving lu-
ciferase reporter gene transcription) was co-transfected into
Vero cells with different amounts of pSHhr1 (a plasmid con-
taining only the hr1 element cloned in pUC18). pUC18 in
appropriate concentration was added to the transfection mix to
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ensure identical amount of total transfected DNA. When Vero
cells were transfected with the same amount of pBVluc and
increasing amounts (4, 8, and 16 g) of pSHhr1, an increase in
luciferase expression is observed as a direct function of pSHhr1
concentration (Fig. 3). These results demonstrate that hr1 se-
quence can act as an enhancer when present in trans. Further-
more, this enhancement is a direct function of the concentra-
tion of the enhancer-carrying plasmid, pSHhr1, in transiently
transfected cells.
hr1-BP-like Factors in the Mammalian Nuclear Extract In-
teract Specifically with hr1—The complete hr1 is a 750-bp
fragment containing five imperfect palindromes (shown as dou-
ble-outward arrows in Fig. 4A) with EcoRI site at the center of
each palindrome. A complete enhancer module carries an
EcoRI palindrome and flanking sequences. Using suitable re-
striction enzyme sites hr1 was digested into smaller fragments
to generate constructs with varying number of palindromes
and flanking sequences (Fig. 4A). The 170-bp single-enhancer
module was used in an electrophoretic mobility shift assay
(EMSA) to detect for the presence of hr1-binding proteins in
mammalian cells. A distinct retardation in the migration of the
labeled 170-bp fragment can be seen when the fragment is
incubated with mammalian Vero cell nuclear extract (Fig. 4B).
The binding of one or more of the Vero cell nuclear factors to
hr1 is specific, and this is evident from the observation that the
complex can be competed with cold 170-bp hr1 but not with
heterologous competitor like pUC18, even when present in high
molar excesses. 20- and 40-fold molar excess of cold 170-bp hr1
competitor abolishes the binding (lanes 3 and 4), whereas sim-
ilar molar excesses of pUC18 (a heterologous competitor) has
no effect (lane 5 and 6), demonstrating the specificity of the
binding. 90-, 330-, and 420-bp fragments could also bind with
high specificity to the mammalian hr1-binding protein (mhr1-
BP) present within the mammalian cell nuclear extract (data
not shown). These results demonstrate that factors present in
mammalian cells interact with high specificity with the hr1
element.
FIG. 1. A, a schematic representation of the plasmids used for trans-
fections. pBVluc carries the CMV promoter driving the luciferase re-
porter. pBVluc-hr1-U1 has hr1 cloned upstream of the CMV promoter in
the same orientation as that in the virus. In pBVluc-hr1-U2, hr1 is
upstream but in the opposite orientation. pBVluc-hr1-U1-U1 has two hr
sequences upstream, pBVluc-hr1-D1 has hr1 downstream in the correct
orientation, and pBVluc-hr1-D2 has hr1 downstream but in the opposite
orientation. pBVluc-hr1-D1-D1 has two hr sequences downstream to the
promoter-reporter cassette. The numbers in the parentheses denote the
sizes (in kb) of the respective plasmids. B, expression from the CMV
promoter in mammalian cells is enhanced by hr1 in transient expres-
sion assays. Vero cells were transfected with control plasmid pBVluc
(without hr1) and plasmids carrying hr1 placed in different positions
and orientation as shown in Fig. 1A. The first bar represents the
luciferase activity of the cells transfected with pBVluc, assayed 36 h
post transfection. The second, third, fourth, fifth, sixth, and seventh bars
show the luciferase activity after transfection with plasmid pBVluc-hr1-
U1, pBVluc-hr1-U2, pBVluc-hr1-U1-U1, pBVluc-hr1-D1, pBVluc-hr1-D2,
and pBVluc-hr1-D1-D1, respectively.
FIG. 2. hr1 can enhance transcription from hsp70 promoter in
mammalian cells. Vero cells were transfected with a control plasmid
pUClacluc, containing hsp70 promoter and -galactosidase reporter
(filled bar) and pBVlacluc-hr1, which has hr1 cloned downstream of the
promoter-reporter (shaded bar). The levels of -galactosidase activity in
Vero cells assayed 36 h post transfection are shown.
FIG. 3. hr1 can as well function in trans in mammalian cells.
The luciferase activity in Vero cells were assayed 36 h after transfection
with 2 g of pBVluc alone (1) or along with 4 g (2) or 8 g (3) or 16 g
of pSHhr1 (4).
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Effect of DNA Binding Drugs on the Enhancer-Nuclear Fac-
tor Interaction—Actinomycin D is a drug that binds to the
minor groove of the DNA, whereas methyl green binds to the
major groove. The 170-bp hr1 probe was incubated alone (Fig.
5, lane 1), or with 0.5 mM actinomycin D (lane 2), or 0.5 mM
methyl green (lane 8), or with the addition of Vero cell nuclear
extract along with different concentrations of actinomycin D
(lanes 4–7) or methyl green (lanes 10–13). Complex formation
was analyzed by gel retardation assay. It could be seen that
increasing concentrations of actinomycin D or methyl green
causes a reduction of the DNA-protein complex (Fig. 5, shown
by an arrow), although this effect was more evident at higher
concentrations of the drugs. As both the major and minor
groove-binding drugs at higher concentrations inhibit the hr1-
host factor interaction, it appears likely that the interaction of
mhr1-BP with the hr1 DNA overlaps both the grooves.
Divalent Cations Destabilize the Binding of hr1 to hr1-BP,
Whereas Monovalent Cations Stabilize the Binding—In an
EMSA where the Vero cell nuclear extract and the 170-bp hr1
probe is incubated with increasing concentration (5–125 mM) of
MgCl2, a gradual decrease in the binding is apparent (Fig. 6
shown by an arrow). At concentrations higher than 50 mM a
total loss of binding is seen (Fig. 6). Incubation with monova-
lent cation KCl generates an opposite pattern. At lower than
125 mM concentration of KCl, binding is very weak, however, at
a concentration of 1000 mM, a very tight binding is observed
(data not shown). These results demonstrate that, although
divalent cations destabilize the hr1-mhr1-BP interactions,
monovalent cations stabilize the same.
The One or More Nuclear Factors That Bind to hr1 in Sf9 and
Mammalian Cells Are Not the Same—The AcMNPV hr1 binds
to the Sf9 insect cell host protein, hr1-BP, and this binding is
crucial for the enhancer function. Having shown that mamma-
lian cells, even though they are not natural hosts to AcMNPV
infection, do contain one or more factors that binds to hr1 we
investigated whether these factor(s) is(are) similar to those
present in Sf9 insect cells. In an EMSA, the 170-bp probe was
incubated with 2 g of Sf9 nuclear extract and 2 g of Vero
nuclear extract. The DNA-protein complex in the two cases has
different mobilities (Fig. 7, compare lane 1 with lane 2). When
2 g of the Vero and Sf9 extracts are incubated together,
independent complexes corresponding to complexes generated
by the individual extracts are seen (Fig. 7, lane 3). Moreover,
when binding reactions were carried out under limiting con-
centrations of probe and 2 g each of Sf9 and Vero extracts, the
results were similar. This implies that the hr1-binding proteins
in the two nuclear extracts are of different molecular sizes and
perhaps involve different protein-protein interactions, whereas
complexing with hr1 and/or bind to different regions within the
hr1, hence they do not compete out each other. These results
suggest that, although the mammalian cells indeed contain one
or more factors that bind to hr1, these factors are different from
the Sf9 hr1-BP in terms of their molecular sizes and possible
cognate sequence motifs and/or protein partners involved in
such an interaction.
hr1 Cannot Function as a Replication Origin in Mammalian
Cells—In Sf9 cells, hr1 also functions as an origin of replica-
tion. The ori and enhancer activities are independent of each
other and are detected using different transfection regimes (8).
The ori activity is scored by a standard method, which is based
on the sensitivity of the isolated plasmid to DpnI restriction
digestion, which recognizes the target site to be methylated
with Dam methylase (15). Escherichia coli, which is Dam will
methylate adenine residue within the GATC recognition site
for DpnI, and consequently all its DNA will be digested by the
enzyme. However, plasmid DNA that is replicated in mamma-
lian cells (Dam) will not be methylated at GATC sequence and
will therefore be resistant to DpnI digestion. Thus, DpnI can
differentiate input plasmid DNA from that which has indeed
replicated in the eukaryotic cell. DNA was isolated from mam-
malian cells transfected with pUC18 and pSHhr1, followed by
AcMNPV viral infection after a 24-h gap to ensure the presence
of viral factors required for ori function. A control where cells
were transfected with pSHhr1 but not infected with virus was
also included to check if the hr1 ori activity can occur even in
the absence of viral infection. Total DNA was isolated after
different time points (6, 12, 24, and 36 h) post-infection or
post-transfection (in case of uninfected cells) and assayed for
DpnI digestibility. In the control Sf9 cells, a high molecular
FIG. 4. A, a schematic map of the 750-bp hr1. The five 28-bp core
palindromes are shown as filled double arrows. There is an EcoRI site
at the center of each palindrome the sequence of which is shown. Using
different restriction enzymes, hr1 can be fragmented to generate differ-
ent combinations of palindrome and inter-palindrome sequences. B, hr1
binds with high affinity to a nuclear factor in mammalian cells. Nuclear
extract (2 g) from Vero cells was incubated with 1 ng of the 170-bp
radiolabeled hr1 probe in binding reactions for electrophoretic mobility
shift assays. The mobility of free probe is shown in lane 1. A distinct
retardation in the mobility of the probe is seen when it is incubated with
Vero nuclear extract (lane 2). 20- and 40-fold molar excess of cold 170-bp
hr1 competitor abolishes the binding (lane 3 and 4). Similar molar
excesses of pUC18 (a heterologous competitor) did not affect the retar-
dation, showing the specificity of the binding (lane 5 and 6).
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weight DpnI-resistant form is seen in cells transfected with
pSHhr1 followed by viral infection (Fig. 8A, lanes 6, 12, 18, and
24), whereas cells transfected with pSHhr1 but not followed by
viral infection do not show any resistant form but were easily
digested with DpnI (Fig. 8A, lanes 4, 10, 16, and 22) pointing to
their unreplicated status. Cells transfected with pUC18 fol-
lowed by viral infection are also sensitive to DpnI (Fig. 8A,
lanes 2, 8, 14, and 20) reflecting their unreplicated status. In
contrast, a DpnI-resistant band is not detected at any point in
mammalian HepG2 cells, even in cells transfected with pSHhr1
followed by viral infection (Fig. 8B, lanes 6, 12, 18, and 24).
Thus, although in the control Sf9 insect cells, the hr1-contain-
ing plasmid can support replication in the presence of viral
infection hr1 fails to function as an origin of replication in
mammalian cells.
A Recombinant Virus Containing Two Promoters Can Infect
Mammalian Cells, However, Only the hsp70 Promoter Is Func-
tional Not the Polyhedrin Promoter—Baculoviruses do not rep-
licate in mammalian cells but can enter the cells through a
passive endosomal pathway. A recombinant virus containing
two promoters and two reporters, luciferase under the control
of the baculoviral polh promoter and -galactosidase under the
hsp70 promoter, was used to infect different mammalian cells
and control Sf9 cells. After different time points post infection
luciferase and -galactosidase assays were performed. In the
control Sf9 cells (Fig. 9A), luciferase activity follows the typical
time profile of polh promoter. Luciferase is detectable at
12 h.p.i., increases steadily from 24 to 36 h.p.i., and is very high
at 48 h.p.i. In mammalian cells, there is no luciferase activity
(data not shown), which is expected given the fact that polh
promoter requires baculovirus encoded factors. The -galacto-
sidase activity follows a completely different profile. In Sf9 cells
this activity, detectable as early as 6 h.p.i., increases only
marginally from 12 h.p.i. up to 48 h.p.i. (Fig. 9B, filled bars).
The -galactosidase activity in mammalian cells is very much
lower than in insect cells. In COS-1 cells (Fig. 9B, white bars)
and HepG2 cells (Fig. 9B, shaded bars), the -galactosidase
activity is detectable at 6 h.p.i., increasing only marginally
from 6 to 48 h.p.i. It is interesting to highlight that the ob-
served overwhelming quantitative differences between Sf9 in-
sect cells vis-a`-vis mammalian cells is a combined reflection of
the replication of baculovirus in the insect cells as well as
increased efficiency of the hsp70 promoter. The Drosophila
FIG. 5. Both the major and minor
groove binding drugs have an effect
on the interaction of hr1 to mhr1-BP.
The 170-bp hr1 probe was incubated
alone (lane 1), or with 0.5 mM actinomycin
D (lane 2), or with 0.5 mM methyl green
(lane 8) or with just the nuclear extract
(lanes 3 and 9). The probe was incubated
with different concentrations of actinomy-
cin D as shown (lanes 4–7) or methyl
green (lanes 10–13), and Vero cell nuclear
extract was added subsequently. Complex
formation (shown by an arrow) was ana-
lyzed by gel retardation assay.
FIG. 6. Divalent cations destabilize
the binding of hr1 to mhr1-BP. Bind-
ing reactions were carried out with Vero
nuclear extract and the 170-bp probe at
MgCl2 concentrations ranging from 5 to
125 mM (lanes 3–12). Lane 1, free probe.
Lane 2, probe with nuclear extract with
no additional MgCl2. With increasing
amounts of MgCl2 there is a decrease in
binding (shown by an arrow).
FIG. 7. The Sf9 hr1-BP and mhr1-BP are distinct from each
other. 1 ng of 170-bp hr1 probe was incubated with 2 g each of Sf9
(lane 1), Vero (lane 2), or both Vero and Sf9 extracts (lane 3). In
competition experiments, 2 g each of Sf9 and Vero extracts were
incubated with either 0.5 ng (lane 4) or 0.25 ng (lane 5) or 0.1 ng (lane
6) of 170-bp hr1 probe.
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hsp70 promoter is expectedly more active in a homologous
insect cell environment than in a mammalian cell.
Introduction of an Additional hr1 in the Recombinant Virus
Increases the Expression from the hsp70 Promoter in Mamma-
lian Cells—Having shown that the hr1 sequence element can
enhance transcription from hsp70 promoter in transient trans-
fections in mammalian cells, we checked for hr1-mediated en-
hancement when it is present as an additional copy in the
virus. A recombinant virus (vAclacluc-hr1) was constructed by
introducing an additional copy of the hr1 enhancer stably in-
tegrated into the vAclacluc (10, 11). More than 2-fold enhance-
ment of expression of -galactosidase in mammalian cells from
hsp70 promoter was seen when vAclacluc-hr1 was used as
compared with vAclacluc (Fig. 10). It is important to note that,
unlike Sf9 insect cells, mammalian cells do not support bacu-
lovirus replication and even then hr1 could enhance expression
of a reporter gene driven by a relatively inefficient heterologous
insect promoter.
DISCUSSION
The baculovirus AcMNPV hr1, the enhancer under study, is
bifunctional, in that it can function both as an enhancer of
transcription and an origin of replication. Spodoptera frugi-
perda insect cells (Sf9) are the natural hosts for AcMNPV,
which follows a temporal profile of gene expression and has
been used to express heterologous genes. hr1 can act to en-
hance the expression of genes during all the different phases of
infection; the immediate early gene ie-N (or ie-2), the delayed
early 39k gene (7, 15, 16), the late gene cor and very late polh
(8). A number of reasons such as the dual role of hr1, its ability
to enhance transcription from a wide range of promoters within
the host system by recruiting a host factor hr1-BP (9), the
FIG. 8. A, hr1 does not function as an ori of replication in mammalian cells. The control Sf9 cells were transfected with pUC18 followed by
infection with AcMNPV (lanes 1, 2, 7, 8, 13, 14, 19, and 20), and total DNA was isolated at different time points (6, 12, 24, and 36 h) post infection.
In another experiment, cells were transfected with an hr1-containing plasmid (pSHhr1) without any viral infection (lanes 3, 4, 9, 10, 15, 16, 21,
and 22) or followed by infection (lanes 5, 6, 11, 12, 17, 18, 23, and 24). The total DNA isolated was further digested with HindIII alone to linearize
the plasmid (all odd lanes) or digested with both HindIII and DpnI (all even lanes) and analyzed for DpnI sensitivity. Lanes where cells were
transfected with pSHhr1 followed by infection with virus show the appearance of a DpnI-insensitive band indicating that hr1 works as an ori of
replication in these cells. B, DpnI sensitivity assay to score for hr1 ori activity in HepG2 mammalian cells. HepG2 cells were transfected with
pUC18 (lanes 1, 2, 7, 8, 13, 14, 19, and 20) followed by infection with AcMNPV. The total DNA was isolated at different time points (6, 12, 24, and
36 h) post infection. In parallel experiment, HepG2 cells were transfected with a hr1 containing plasmid (pSHhr1) without any viral infection (lanes
3, 4, 9, 10, 15, 16, 21, and 22) or followed by infection (lanes 5, 6, 11, 12, 17, 18, 23, and 24). The total DNA isolated was further digested with
HindIII alone to linearize the plasmid (all odd lanes) or digested with both HindIII and DpnI (all even lanes) and analyzed for DpnI sensitivity.
Absence of any DpnI-insensitive band implies that hr1 cannot function as an ori in mammalian cells.
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utility of baculovirus-mediated gene transfer into mammalian
cells, etc., tempted us to analyze the role of hr1 in mammalian
cells and the identification of host factors that could interact
with hr1. A search for sequence motifs that interact with
known enhancer binding proteins and transcription factors in
other viral and animal systems revealed that indeed quite a
few of these motifs were present in hr1. The most interesting
were the motifs with high homology to the consensus enhancer
element motif recognized by the C/EBP family of transcription
factors in the long terminal repeat enhancer of the avian leu-
kemia virus (17). This motif was repeated (with 1- or 2-bp
changes) 3 to each palindrome in hr1. This motif is inciden-
tally within the region in the flanking sequences, which exhibit
high levels of homology.
We have demonstrated that hr1 behaves as a classic en-
hancer of transcription from the CMV promoter in mammalian
cells such as kidney cells (Vero and COS-1), liver cells (HepG2),
HeLa and porcine cells (PS-1). Enhancement was also seen
when the Drosophila hsp70 promoter is used. Furthermore,
hr1-mediated action was independent of the reporter gene
used. The maximum enhancement was observed in Vero cells,
where a consistent 3-fold enhancement was observed in hr1-
containing plasmids over control non-hr1 plasmids. In Sf9
cells, the binding of host factor hr1-BP to hr1 is critical for its
enhancer function. Identification of specific nuclear factors
present in mammalian cells (mhr1-BP) that bind with high
affinity and specificity to different regions of hr1 was consistent
with the ability of hr1 to function in non-insect host environ-
ment. mhr1-BP and hr1-BP are distinct from each other in
terms of their molecular sizes, their ion requirements for bind-
ing, and the manner in which they approach the DNA.
Enhancers are usually cis-acting DNA sequences that up-
regulate gene expression, the exact mechanism of which is not
clear though several models have been put forward. We have
demonstrated for the first time that hr1 is capable of enhancing
transcription even in trans, i.e. when it is present on another
plasmid during co-transfections. There are reports that an
enhancer can have effect on another DNA molecule when pres-
ent in trans (13, 14). The long range action of enhancers include
their ability to stimulate transcription across homologues. In
Drosophila, these effects are called transvection. In certain
combinations the cuticle pigmentation gene, called yellow, dis-
play intra-allelic complementation, as a result of the action of
tissue-specific yellow enhancers present on one chromosome
stimulating transcription from the yellow promoter located on
the paired homologue (18). Although hr1 can exert its influence
when present both in “cis” and “trans” in mammalian cells, it
can act only in “cis” in insect cells. This could be due to the
difference in the properties of the enhancer binding proteins in
the two cases (Sf9 hr1-BP and mhr1-BP). mhr1-BP by virtue of
its protein-protein interactions may be able to bring about
enhancement of transcription from promoters present on an-
other plasmid molecule.
hr1-BP has little or no role in the ori function of hr1 (8, 9),
therefore the presence of hr1-BP like factors in mammalian
cells should not be of any consequence as far as the ori function
is concerned. This was indeed the case as was evident from the
inability of the hr1 to support replication in mammalian cells.
This also explains why baculoviruses can though enter and
transiently express foreign genes in mammalian cells, they
cannot replicate in these cells. One could speculate that repli-
cation is a more host-specific phenomenon than transcription
involving hr and non-hr origins of replication (19). Several
recent reports have demonstrated that primary human hepa-
tocytes, cell lines of hepatic origin, and other tumor cell lines
were able to efficiently take up and transiently express foreign
genes under the control of constitutive mammalian promoters
FIG. 10. Presence of an additional copy of hr1 in the virus
enhances the expression of hsp70 promoter-driven -galactosid-
ase expression in mammalian cells. Mammalian cells were infected
with two recombinant viruses, vAclacluc (filled bars) and vAclacluc-hr1
(shaded bars) and assayed for -galactosidase activity at different time
points post infection. The virus containing additional hr1 expresses to
higher levels than the virus with only one copy of hr1.
FIG. 9. Differential reporter gene expression in Sf9 and mam-
malian cells. Mammalian cells and control Sf9 cells were infected with
the virus vAclacluc at 10 multiplicity of infection. A, luciferase activity
of Sf9 cells was assayed at different time points post infection 6 h (bar
1), 12 h (bar 2), 24 h (bar 3), 36 h (bar 4), and 48 h (bar 5). B, the
-galactosidase of activity of mammalian cells (COS-1 cells, white bars;
HepG2 cells, shaded bars) and control Sf9 cells (filled bars) at different
h.p.i. is shown.
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using baculoviruses as delivery vehicles (20–24). High level
reporter gene expression from heterologous promoters (8, 21)
was observed in human and rabbit hepatocytes in vitro,
whereas mouse hepatocytes and some other epithelial cell
types are targeted at lower rates. The efficiency of baculovirus-
mediated entry of foreign genes via an endosomal pathway
considerably exceeds that by lipid transfection (20). Another
report shows that baculovirus promoters in mammalian cells
can be activated by adenovirus functions (25). Baculoviruses,
therefore, offer an interesting alternative for a safe, self-limit-
ing gene delivery system for gene therapy (24, 26). These vi-
ruses provide an added advantage by their ability to package
inserts greater than 10 kb. The dual promoter reporter recom-
binant virus used here provides an ideal tool to study baculo-
virus-mediated gene delivery into mammalian cells. The bacu-
lovirus polyhedrin gene promoter requires insect cell host
factors (27–33) for its activation and therefore cannot function
in a non-insect environment. The transcription ability of the
constitutive hsp70 promoter, however, is relatively uniform in
different cell lines, except that HepG2 cells show higher levels
of reporter activity, consistent with earlier reports that these
cells are able to take up baculoviruses more efficiently than
other cell lines. The presence of an additional copy of hr1
increases the -galactosidase expression thereby providing a
system for improving the expression of genes delivered via
baculovirus in mammalian cells. hr1 therefore can play a major
role in enhancing expression of foreign gene in these cells.
Baculoviruses have long been used as biopesticides, owing to
their small host range. It is possible now to manipulate the
virus so as to increase its host range. Although the ability of the
hr1 enhancer (10, 34) to activate transcription and support
DNA replication in insect cells can be further exploited (35), the
fact that hr1 can positively regulate non-baculoviral promoters
both in transient transfections and viral infections without
affecting replication makes it an ideal candidate for value
addition in baculovirus-mediated gene delivery in mammalian
cells (22, 36).
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